000 | 01722 a2200481 4500 | ||
---|---|---|---|
005 | 20250512055330.0 | ||
264 | 0 | _c19860321 | |
008 | 198603s 0 0 eng d | ||
022 | _a0009-7322 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aColucci, W S | |
245 | 0 | 0 |
_aMilrinone and dobutamine in severe heart failure: differing hemodynamic effects and individual patient responsiveness. _h[electronic resource] |
260 |
_bCirculation _cMar 1986 |
||
300 |
_aIII175-83 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aBlood Pressure _xdrug effects |
650 | 0 | 4 |
_aCardiac Output _xdrug effects |
650 | 0 | 4 |
_aCardiotonic Agents _xadministration & dosage |
650 | 0 | 4 | _aClinical Trials as Topic |
650 | 0 | 4 |
_aDobutamine _xadministration & dosage |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aHeart Failure _xdrug therapy |
650 | 0 | 4 |
_aHeart Rate _xdrug effects |
650 | 0 | 4 |
_aHemodynamics _xdrug effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aMilrinone |
650 | 0 | 4 |
_aMyocardial Contraction _xdrug effects |
650 | 0 | 4 |
_aNitroprusside _xpharmacology |
650 | 0 | 4 |
_aNorepinephrine _xblood |
650 | 0 | 4 |
_aPyridones _xadministration & dosage |
650 | 0 | 4 | _aStimulation, Chemical |
650 | 0 | 4 |
_aVascular Resistance _xdrug effects |
650 | 0 | 4 |
_aVasodilation _xdrug effects |
700 | 1 | _aWright, R F | |
700 | 1 | _aJaski, B E | |
700 | 1 | _aFifer, M A | |
700 | 1 | _aBraunwald, E | |
773 | 0 |
_tCirculation _gvol. 73 _gno. 3 Pt 2 _gp. III175-83 |
|
999 |
_c3516500 _d3516500 |